# A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

> **NCT05504317** · PHASE1 · COMPLETED · sponsor: **Akeso** · enrollment: 48 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** AK111
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05504317
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-28
- **Primary completion:** 2021-03-02
- **Final completion:** 2021-03-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05504317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05504317, "A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05504317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*